Scientists have discovered that rogue DNA rings, called extrachromosomal DNA (ecDNA), appear early in glioblastoma and drive its rapid growth and resistance to therapy.

And it has paved the way for other therapeutic strategies, including the first gene therapy delivered through skin grafts, ...

A domestic research team has developed a gene scissors technology that kills only the mutated DNA of cancer cells by cutting ...

In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" ...

Scientists at the National Institute of Standards and Technology (NIST) have developed a new technology for measuring how ...

The mechanism behind the expression of the tumor gene 'BCL3' has been identified, raising expectations that this will have a ...

New research shows rapamycin’s powers go beyond slowing cell growth. It appears to shield DNA itself from damage. Since DNA ...

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international team publishes landmark studies detailing new findings and potential therapies.

Once dismissed as “junk” DNA, ancient viruses embedded in the human genome play a key role in early human development, ...

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and restored mobility, pointing to a potential non‑opioid ...

Clinuvel is exploring other potential indications for Scenesse. This includes vitiligo, and potentially, DNA repair, which accounts for 17% of our fair value estimate.